Results 131 to 140 of about 21,652 (222)

Successful Midterm Management With an Herbal Decoction, Modified-Goshajinkigan (mGJG) for Non-Proliferative Diabetic Retinopathy: A Case Study

, 2018
Jiman Kim, Eulsun Moon, Tae‐Hun Kim
openalex   +1 more source

Nutritional and Health Potential of Edible Seeds: Micronutrient Bioavailability and Mechanistic Insights

Food Science &Nutrition, Volume 14, Issue 2, February 2026.
Their bioactive constituents act through antioxidant, anti‐inflammatory, and metabolic‐regulating mechanisms, validating their classification as functional foods. Evidence from clinical and biochemical studies largely supports these benefits, although some claims stem from preliminary or in vitro findings.
Nighat Raza, Alina Sadaf, Reeha Mushtaq, Mirza Abid Mehmood, Luqman Amrao, Fakhar Islam, Muhammad Afzaal, Mohd Asif Shah   +7 more
wiley   +1 more source

Effect of Pioglitazone therapy on Early Non Proliferative Diabetic Retinopathy

, 2019
Dr Shikha Agarwal
openalex   +1 more source

Accurate detection of non-proliferative diabetic retinopathy in optical coherence tomography images using convolutional neural networks [PDF]

, 2019
Mohammed Ghazal, Samr Ali, Ali Mahmoud, Ahmed Shalaby, Ayman El‐Baz   +4 more
openalex   +1 more source

The Relationship between Central Macular Thickness and Metabolic Parameters Changes in Patients with Non-Proliferative Diabetic Retinopathy

, 2021
Ayşe Altıntaş, Çağrı İlhan, Mehmet Çıtırık   +2 more
openalex   +1 more source

MSC‐Derived Exosomal lnc‐AGT‐3: A Novel Anti‐Angiogenic Target in Age‐Related Macular Degeneration Through p53 Signaling Pathway

Aging Cell, Volume 25, Issue 2, February 2026.
MSC‐derived exosomes deliver lnc‐AGT‐3 to vascular endothelial cells, where it binds hnRNP K in the nucleus. This interaction inhibits p53 ubiquitination, enhancing p53 stabilization and transcriptional activation of anti‐angiogenic targets TSP1. Consequently, p53‐mediated signaling is potentiated, effectively suppressing choroidal neovascularization ...
Lingjie Kong, Xiaoyan Han, Siyi Qi, Duo Li, Jingyue Zhang, Linyu Zhang, Shujie Zhang, Qin Jiang, Biao Yan, Chen Zhao   +9 more
wiley   +1 more source

Normal parathyroid hormone and non-proliferative diabetic retinopathy in patients with type 2 diabetes. [PDF]

J Diabetes Investig, 2021
Sun S, Wang Y, Ma W, Cheng B, Dong B, Zhao Y, Hu J, Zhou Y, Huang Y, Wei F, Wang Y.   +10 more
europepmc   +1 more source

Severity of complications is associated with impaired health‐related quality of life in people with type 1 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1201-1212, February 2026.
Abstract Aims Health‐related quality of life (HRQoL) assessment is increasingly integrated into type 1 diabetes (T1D) monitoring to promote a holistic approach. To investigate HRQoL in adults with T1D and to assess the impact of the severity of complications on HRQoL.
Sara Barraud, Gloria A. Aguayo, Emmanuel Cosson, Chloé Amouyal, Sylvie Feldman, Jean‐François Gautier, Patricia Vaduva, Samy Hadjadj, Hélène Hanaire, Laurence Kessler, Emmanuelle Lecornet‐Sokol, Pascale Massin, Louis Potier, Eric Renard, Yves Reznik, Agnès Sola, Anne Vambergue, Camille Vatier, Bruno Vergès, Jean‐Pierre Riveline, Guy Fagherazzi   +20 more
wiley   +1 more source

SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register‐based randomised trial on prevention of diabetic complications

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1327-1338, February 2026.
Abstract Aims Metformin has hitherto not been proven superior to other type 2 diabetes (T2D) medications for the prevention of organ complications. The aim of this study is to report baseline data and blinded interim analyses in the register‐based randomised clinical trial (RRCT) SMARTEST, which compares metformin and the SGLT2 inhibitor dapagliflozin ...
Jan W. Eriksson, Giovanni Fanni, Martin H. Lundqvist, Stefan Jansson, Karin Rådholm, Sheyda Sofizadeh, Vagia Patsoukaki, Albert Nilsson, Daniel Lindholm, Olov Rolandsson, Anna Norhammar, Elisabet Granstam, Björn Eliasson, Louise Bennet, Johan Sundström   +14 more
wiley   +1 more source

Intravitreal aflibercept partially reverses severe non-proliferative diabetic retinopathy in treatment-naïve patients. [PDF]

J Int Med Res, 2021
Tao Y, Jiang P, Liu M, Liu Y, Song L, Wang H.   +5 more
europepmc   +1 more source